Lifecore Biomedical Inc. (LFCR) — Net Asset Quality Index
Lifecore Biomedical Inc. (LFCR) has a Net Asset Quality Index of 9.2% as of February 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $225.50 Million minus total liabilities of $204.72 Million yields net assets of $20.78 Million. A higher index indicates a stronger, lower-leverage balance sheet. Check how resilient are Lifecore Biomedical Inc.'s assets to evaluate the company's liquid asset resilience ratio.
Quality Index
Net Assets
Total Assets
Total Liabilities
Lifecore Biomedical Inc. Net Asset Quality Index Over Time (1996–2025)
This chart shows how Lifecore Biomedical Inc.'s Net Asset Quality Index has evolved across 30 annual periods from 1996 to 2025. As of February 2026, the index stands at 9.2%, representing net assets of $20.78 Million against total assets of $225.50 Million USD. See working capital to net assets of Lifecore Biomedical Inc. to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for Lifecore Biomedical Inc. (1996–2025)
The table below presents the year-by-year Net Asset Quality Index for Lifecore Biomedical Inc. from 1996 to 2025, covering 30 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see market cap of Lifecore Biomedical Inc..
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 0.6% | $1.34 Million | $239.34 Million | $238.01 Million | ▼ -3.9 pp |
| 2024 | 4.5% | $11.31 Million | $253.96 Million | $242.65 Million | ▼ -27.5 pp |
| 2023 | 32.0% | $87.82 Million | $274.70 Million | $186.88 Million | ▼ -4.6 pp |
| 2022 | 36.6% | $107.94 Million | $295.16 Million | $187.22 Million | ▼ -3.7 pp |
| 2021 | 40.3% | $202.78 Million | $502.92 Million | $300.14 Million | ▼ -2.4 pp |
| 2020 | 42.7% | $231.04 Million | $541.31 Million | $310.27 Million | ▼ -9.4 pp |
| 2019 | 52.0% | $270.14 Million | $519.09 Million | $248.95 Million | ▼ -10.4 pp |
| 2018 | 62.4% | $252.56 Million | $404.70 Million | $152.14 Million | ▼ -1.3 pp |
| 2017 | 63.7% | $228.15 Million | $358.01 Million | $129.86 Million | ▲ +1.9 pp |
| 2016 | 61.8% | $212.35 Million | $343.47 Million | $131.12 Million | ▼ -1.7 pp |
| 2015 | 63.5% | $220.11 Million | $346.46 Million | $126.36 Million | ▼ -1.8 pp |
| 2014 | 65.3% | $204.76 Million | $313.62 Million | $108.86 Million | ▲ +3.3 pp |
| 2013 | 62.0% | $180.41 Million | $290.94 Million | $110.53 Million | ▲ +7.4 pp |
| 2012 | 54.6% | $151.56 Million | $277.69 Million | $126.13 Million | ▼ -12.2 pp |
| 2011 | 66.8% | $137.73 Million | $206.31 Million | $68.59 Million | ▲ +0.6 pp |
| 2010 | 66.2% | $132.47 Million | $200.20 Million | $67.72 Million | ▼ -17.0 pp |
| 2009 | 83.2% | $127.20 Million | $152.87 Million | $25.67 Million | ▲ +6.2 pp |
| 2008 | 77.0% | $116.02 Million | $150.59 Million | $34.57 Million | ▼ -2.2 pp |
| 2007 | 79.3% | $112.07 Million | $141.37 Million | $29.30 Million | ▲ +6.3 pp |
| 2006 | 72.9% | $86.82 Million | $119.03 Million | $32.20 Million | ▼ -0.5 pp |
| 2005 | 73.5% | $73.53 Million | $100.08 Million | $26.55 Million | ▲ +5.6 pp |
| 2004 | 67.8% | $63.10 Million | $93.01 Million | $29.91 Million | ▲ +6.5 pp |
| 2003 | 61.3% | $59.60 Million | $97.17 Million | $37.57 Million | ▲ +8.0 pp |
| 2002 | 53.4% | $57.54 Million | $107.80 Million | $50.26 Million | ▲ +11.0 pp |
| 2001 | 42.4% | $50.87 Million | $120.12 Million | $69.25 Million | ▼ -3.7 pp |
| 2000 | 46.1% | $57.00 Million | $123.73 Million | $66.73 Million | ▼ -32.1 pp |
| 1999 | 78.1% | $31.80 Million | $40.70 Million | $8.90 Million | ▼ -1.3 pp |
| 1998 | 79.5% | $33.70 Million | $42.40 Million | $8.70 Million | ▲ +8.6 pp |
| 1997 | 70.9% | $35.60 Million | $50.20 Million | $14.60 Million | ▼ -24.4 pp |
| 1996 | 95.3% | $36.60 Million | $38.40 Million | $1.80 Million | — |